showed that METTL3 was upregulated in glioblastoma patients with TMZ treatment, and silencing METTL3 inhibited the tumor growth in TMZ-resistant xenograft mouse in combination with TMZ (172). This evidence concerns the gene METTL3 and glioblastoma.